Release Date: 23/08/12 10:24 Summary: ASX Market Release - Suspension Price Sensitive: No Download Document 39.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%